Clinical Trials Logo

Cataract Surgery clinical trials

View clinical trials related to Cataract Surgery.

Filter by:

NCT ID: NCT03587909 Completed - Cataract Surgery Clinical Trials

FLACS vs Phaco in Shallow Anterior Chamber

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Phacoemulsification in eyes with a shallow anterior chamber (ACD < 2.2mm) presents with problems of safe access to the cataract and increased vulnerability of the endothelium and a higher tendency of complications such as descemet's detachment and iris prolapse. A shallow anterior chamber is also responsible for the high incidence of glaucoma and postoperative complications after cataract surgery. Femtosecond assisted cataract surgery has made cataract surgery safer and more predictable. The effective phacoemulsification time and intra-operative manipulation is greatly reduced in FLACS. However phacoemulsification still remains the most widely performed cataract surgery around the world. Post-operative outcomes after phacoemulsification in patients having shallow anterior chamber have been extensively reported in literature over the years. There is no head to head comparison in terms of intraoperative performance and post-operative outcomes between FLACS and phacoemulsification in eyes with shallow anterior chamber. The aim is to compare the intra-operative performance and post-operative outcomes in eyes undergoing femtosecond laser assisted cataract surgery versus eyes undergoing phacoemulsification in eyes having shallow anterior chamber. The study will bring an understanding on the question: Do patients undergoing Femtosecond laser assisted cataract surgery behave differently from those undergoing phacoemulsification?

NCT ID: NCT03375996 Recruiting - Cataract Surgery Clinical Trials

Evaluation of a Protocol of Pupil Dilation Before Laser-assisted Cataract Surgery

MYFLACS
Start date: June 1, 2018
Phase:
Study type: Observational

Laser-assisted cataract surgery is an innovative and growing procedure to improve the safety and results of modern cataract surgery. However, this technique faces to some obstacles: economics in the one hand due to the cost and time spent for the laser procedure before the conventional surgery, and technical in the other hand, especially due to some loss of pupil dilation during the surgery, which is highly important to ensure a perfect procedure. The present study aims at assessing a pharmacological protocol to maintain an accurate pupil dilation all along the surgery in order to improve the whole procedure.

NCT ID: NCT03364972 Completed - Clinical trials for Patient Satisfaction

A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00

Start date: February 6, 2018
Phase: N/A
Study type: Interventional

This is a bilateral randomised controlled study to compare visual performance, refractive outcome, forward light scatter, patient satisfaction and objective measurement of glistenings following insertion of two monofocal, aspheric, hydrophobic acrylic intraocular lenses (IOLs). A new product is compared with an established one.

NCT ID: NCT03020056 Completed - Cataract Surgery Clinical Trials

Impact of Cataract Surgery to Socioeconomic Status in Rural Area

ICSSES
Start date: January 16, 2017
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to investigate the effect of cataract surgery on the socioeconomic status of cataract patients in rural area of Southern China.

NCT ID: NCT02910362 Completed - Cataract Surgery Clinical Trials

Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines

Start date: September 2016
Phase: N/A
Study type: Interventional

This study will measure the dynamic real-time intraocular pressure (IOP) in the anterior chamber during standard phacoemulsification surgery. What is known: - Fluidics control is determined to be one of the primary drivers of physician decision making in choosing phacoemulsification equipment. - Active pressure system fluidic control has a perceived and possibly real (based upon recent literature) improvement in intra-cameral IOP stability and reduced pressure fluctuations. - Improved fluidics can allow for reduced dynamic IOP fluctuations, in-the-bag positioned phaco tip, and intra-cameral fluid flow all of which will likely improve corneal health post-operatively.

NCT ID: NCT02892825 Completed - Cataract Surgery Clinical Trials

Music Listening for Cataract Surgery

MUSICATOP
Start date: February 2, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the effect of music therapy on anxiety and hypertension during cataract surgery procedures performed under topical anaesthesia.

NCT ID: NCT02590523 Suspended - Cataract Surgery Clinical Trials

Intracameral Antibiotic Safety Study

Start date: January 2023
Phase: Phase 3
Study type: Interventional

The goal of this study is to determine the safety (but not efficacy in preventing infection) of sterile-packaged and pre-loaded injectable solutions of both vancomycin and moxifloxacin at certain dosages and concentrations as prepared by a compounding pharmacy when used intracamerally at the time of cataract surgery.

NCT ID: NCT02573610 Completed - Cataract Surgery Clinical Trials

Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery

Start date: September 21, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate superior efficacy of DE-108 ophthalmic solution to that of Levofloxacin 0.5% ophthalmic solution as well as safety of the former used for perioperative bacteria eradication in patients who are scheduled for cataract surgery.

NCT ID: NCT02128113 Completed - Cataract Surgery Clinical Trials

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Start date: May 31, 2014
Phase: Phase 2
Study type: Interventional

This study assesses the efficacy and safety of two concentrations of omaveloxolone (RTA 408) ophthalmic suspension for the prevention of corneal endothelial cell loss following cataract surgery.

NCT ID: NCT01455233 Completed - Cataract Surgery Clinical Trials

2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery

STB-01
Start date: September 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate that Besivance is equal to Vigamox in safety and tolerance when used prophylactically in subjects undergoing routine cataract surgery.